News

2010
14 June

Review of conflict of interest policies in three European medicines regulation agencies
8 June

Medicines manufacturers have clear motives for financing the patient voice
3 June

Quito Declaration
1 June

Independent drug bulletin and assessment reports from Spain – now in English
23 May

Quito Declaration
20 May

EU Global Health Council Conclusions presented at WHA
11 May

EU Ombudsman: Transparency rules apply to all documents held by EMA
10 May

Patient groups not only for sick people's interests – says Portuguese sociologist
6 May

Citizens call for inquiry into EU response to H1N1 outbreak
28 April

European Medicines Agency faces tough questions about patient groups' transparency
28 April

HAI hosts essay competition for students
26 April

EU-India negotiations on FTA pose a serious threat to access to affordable medicines in the developing world
26 April

Patient Groups need dose of transparency
26 April

EU lobby transparency book launch by ALTER-EU
23 April

LAC-EU Alliance for Access to Medicines welcomes compulsory license by Ecuadorian Government
23 April

Roundtable on ACTA by TACD
22 April

Generic prescribing policies 1 – ABPI 0
21 April

Snooping CEO unveils conflicts of interest at the European Medicines Agency
21 April

Where to find ACTA Draft Negotiating Text
2 April

EU Global Health Communication
30 March

Patient advocacy groups: another tool to boost compliance?
29 March

Finnish study: Drug companies see added value of patient group sponsorship
29 March

No NGO briefings will be allowed during World Health Assembly this year.
29 March

HAI Response: ACTA Stakeholders Meeting in European Parliament